Caladrius Biosciences Closes The Sale Of Its Remaining Interest In PCT To Hitachi Chemical Co., Ltd. For $75 Million Post author:Sam Post published:May 18, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Janssen to Terminate Simeprevir License With Medivir, Effective June 2018 December 10, 2017 NeuroDigm Uses Tissue Repair In An Innovative Nerve Pain Model May 11, 2017 Enumeral Biomedical Gets Evicted as it Winds Down Operations August 28, 2017